阿奇霉素序贯治疗小儿支原体肺炎的系统评价

范晓萍; 嵇宏亮

引用本文:	范晓萍,嵇宏亮.阿奇霉素序贯治疗小儿支原体肺炎的系统评价[J].中国现代应用药学,2013,30(10):1139-1141.
	FAN Xiaoping,JI Hongliang.System Evaluation of Azithromycin Sequential Treatment of Mycoplasma Pneumonia in Children[J].Chin J Mod Appl Pharm(中国现代应用药学),2013,30(10):1139-1141.

【打印本页】【HTML】【下载PDF全文】【查看/发表评论】【EndNote】【RefMan】【BibTex】

←前一篇|后一篇→

过刊浏览高级检索

本文已被：浏览 2378次下载 1443次	码上扫一扫！
分享到：微信更多字体:加大+\|默认\|缩小-
阿奇霉素序贯治疗小儿支原体肺炎的系统评价
范晓萍¹, 嵇宏亮²
1.湖州市第一人民医院，浙江湖州 313000;2.湖州市第三人民医院，浙江湖州 313000

摘要:

目的系统评价阿奇霉素序贯治疗小儿支原体肺炎的临床有效性和安全性。方法采用计算机和手工检索相结合的方法，检索2005年1月—2012年9月国内公开发表的有关阿奇霉素序贯治疗小儿支原体肺炎的相关文献，采用RevMan5.0对符合条件的文献进行Meta分析。结果共有9篇文献，737例患者满足纳入标准。合并分析结果显示，临床有效率方面的比数比(OR)为3.87，95%可信区间(CI)为(2.23~6.71)；不良反应发生率方面的OR为0.16，95% CI为(0.11~ 0.24)。结论阿奇霉素序贯治疗小儿支原体肺炎的临床有效率优于对照组，且不良反应少于对照组。

关键词: 阿奇霉素序贯治疗支原体肺炎系统评价

DOI：

分类号:

基金项目:

System Evaluation of Azithromycin Sequential Treatment of Mycoplasma Pneumonia in Children

FAN Xiaoping¹, JI Hongliang²

1.Huzhou No.1 Hospital, Huzhou 313000, China;2.Huzhou No.3 Hospital, Huzhou 313000, China

Abstract:

OBJECTIVE To evaluate the clinical efficacy and safety of azithromycin sequential treatment of mycoplasma pneumonia in children. METHODS Combination of computer and manual search was used. The relevant references on the effect of azithromycin sequential treatment of mycoplasma pneumonia in children which were published from 2005.1 to 2012.9 in China were explored, and Meta-analysis was taken on the qualified references. RESULTS Nine references including 737 patients met inclusion criteria. The systematic review showed that the total effective rate combined OR were 3.87, 95% CI was (2.23-6.71). The incidence of adverse drug reaction combined OR were 0.16, 95% CI was (0.11-0.24). CONCLSUSION The effect of azithromycin sequential treatment of mycoplasma pneumonia in children is better than that in control group. And the adverse reactions is less than the control group.

Key words: azithromycin sequential therapy mycoplasma pneumonia system evaluation